Skip to content
Home/Companies/Biotech/Gyala Therapeutics
Gyala Therapeutics

Gyala Therapeutics

Biotech·Spain·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Gyala Therapeutics?

Gyala Therapeutics is currently owned by Nara Capital Partners through Nara Health Capital (2022 vintage), since 2025. Across its history, Gyala Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-08-03

Nara Capital Partners
Most recent investor
Nara Capital Partners
Nara Health Capital · 2022 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQSpain
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Invivo Partners and Nara Capital Partners since 2020.
Co-invest · 2 holders · 2020 · present
Invivo Partners
2020 · present(6yr) · Invivo Ventures · 2019 · Life Sciences VC
Nara Capital Partners
2025 · present(1yr) · Nara Health Capital · 2022 · Life Sciences VC
Track Gyala Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Gyala Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue